阿尔茨海默病多祖先全基因组相互作用和分层研究与吸烟
Ryan Dacey1,2, Lei Hou1,2, Ashita Gurnani2,3
1Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|November 21, 2025
概括
吸烟与阿尔茨海默氏症 (AD) 风险有关. 在ANKS1B附近的一种特定基因变异 (SNP) 可能会通过影响大脑细胞中的基因表达来增加吸烟者的AD风险.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 流行病学 流行病学
背景情况:
- 阿尔茨海默病 (AD) 已知遗传和环境风险因素.
- 吸烟是AD的重要环境风险因素.
- 人们假设基因与环境的相互作用有助于AD缺失的遗传性.
研究的目的:
- 研究基因与环境的相互作用,特别是阿尔茨海默病中吸烟与遗传因素之间的相互作用.
- 为了确定与吸烟者的AD风险相关的新型遗传基因位置.
主要方法:
- 全基因组关联研究 (GWAS) 和SNP-by-smoking相互作用分析在大型队列 (欧洲和非洲血统) 上进行.
- 进行了吸烟分层关联研究.
- 顶部关联的位置经历了差异性基因表达和局部化分析,使用来自大脑组织的批量和单核RNA测序数据.
主要成果:
- 在APAF1/ANKS1B区域 (rs12368451) 发现了全基因组显著的关联,仅在吸烟者中.
- 这一顶级单核酸多态 (SNP) 表明表达定量特征位 (eQTL) 活动,根据吸烟状态和脑细胞类型而异.
- 在吸烟者中,SNP通过ANKS1B表达在寡细胞中表现出最高的因果关系概率.
结论:
- 在染色体12上的ANKS1B附近的一种新型SNP与吸烟者患阿尔茨海默病的风险有关.
- 这种SNP可能会通过改变ANKS1B表达在寡头细胞中的表达来影响AD风险,这是一种参与粉样前体蛋白加工的基因.
- 在SLC22A23.23内的6号染色体上,在非洲祖先队伍中发现了一种单独的SNP吸烟相互作用.
关键词:
阿尔茨海默氏症的疾病是阿尔茨海默氏症.通过RNA测序进行RNA测序.香烟吸烟吸烟吸烟吸烟吸烟吸烟吸烟吸烟吸烟吸烟基因表达的基因表达方式基因与环境的相互作用全基因组关联研究研究.多个祖先的多个祖先.更多相关视频
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.3K
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.7K
相关概念视频
01:11Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772